Ishita Drugs & Industries Ltd. logo

Ishita Drugs & Industries Ltd. (ISHITADR)

Market Closed
7 Aug, 22:00
MSE MSE
74. 37
-2.63
-3.4156%
- Market Cap
- P/E Ratio
- Div Yield
1,233 Volume
- Eps
77
Previous Close
Add Transaction
Day Range
73.91 78.69
Year Range
66 90.85
Want to track ISHITADR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ISHITADR closed Friday lower at ₹74.37, a decrease of -3.4156% from Thursday's close, completing a monthly decrease of -1.8865% or -₹1.43. Over the past 12 months, ISHITADR stock lost -8.0603%.
ISHITADR is not paying dividends to its shareholders.
The last earnings report, released on May 30, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

ISHITADR Chart

Ishita Drugs & Industries Ltd. (ISHITADR) FAQ

What is the stock price today?

The current price is ₹74.37.

On which exchange is it traded?

Ishita Drugs & Industries Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is ISHITADR.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Ishita Drugs & Industries Ltd. ever had a stock split?

No, there has never been a stock split.

Ishita Drugs & Industries Ltd. Profile

- Industry
- Sector
- CEO
MSE Exchange
INE806D01016 ISIN
India Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Ishita Drugs & Industries Ltd. represents a significant player in the pharmaceutical sector, focusing on the production and marketing of a comprehensive array of pharmaceutical products and drug formulations. With a strong emphasis on manufacturing bulk drugs and specialty chemicals, the company plays a pivotal role in supporting various therapeutic areas through its essential components. The commitment of Ishita Drugs to quality control and the ongoing investment in research and development underscore its dedication to innovation and the enhancement of its product range. Serving the healthcare sector, Ishita Drugs ensures its products are widely available to hospitals, clinics, and medical professionals, contributing vitally to healthcare needs and the pharmaceutical supply chain. The company's strategic approach and quality focus underscore its mission to impact the industry positively, making essential medications more accessible and supporting the global healthcare infrastructure.

Products and Services

Ishita Drugs & Industries Ltd. offers a diverse portfolio of products and services designed to meet the wide-ranging needs of the healthcare and pharmaceutical industries:

  • Bulk Drugs: Ishita Drugs specializes in the production of bulk drugs, which are key active pharmaceutical ingredients (APIs) used in creating various drug formulations. These APIs are crucial for the development of medications across different therapeutic classes, enabling treatment for a myriad of health conditions.
  • Specialty Chemicals: The company also focuses on manufacturing specialty chemicals, which are used in the production of pharmaceuticals and as intermediates in the synthesis of complex drugs. These chemicals are essential for creating high-quality, effective medications that meet rigorous healthcare standards.
  • Research and Development: Ishita Drugs is committed to investing in research and development activities to foster innovation within its product lineup. This commitment allows the company to not only improve existing pharmaceutical products but also to develop new formulations and drug solutions that address emerging healthcare challenges.
  • Quality Control: Ensuring the highest quality standards in all products and processes is a cornerstone of Ishita Drugs' operations. By implementing rigorous quality control measures, the company guarantees the safety, efficacy, and reliability of its pharmaceutical products, thereby supporting the health and wellbeing of patients globally.

Contact Information

Address: -
Phone: -